Do patients receiving whole-brain radiotherapy for brain metastases from renal cell carcinoma benefit from escalation of the radiation dose?

International Journal of Radiation Oncology Biology Physics

Volumn 78, Issue 2, 2010, Pages 398-403

  Rades, Dirk ^a,b   Heisterkamp, Christine ^a   Schild, Steven E ^c  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^b UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^c MAYO CLINIC   (United States)

Author keywords

Brain metastases; Local control; Overall survival; Renal cell carcinoma; Whole brain radiotherapy

Indexed keywords

BRAIN METASTASIS; LOCAL CONTROL; OVERALL SURVIVAL; RENAL CELL CARCINOMA; WHOLE BRAIN RADIOTHERAPY;

BRAIN; MULTIVARIANT ANALYSIS; RADIOTHERAPY; REGRESSION ANALYSIS;

PATHOLOGY;

ADULT; AGE; AGED; ARTICLE; BRAIN METASTASIS; BRAIN RADIATION; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; HUMAN; KARNOFSKY PERFORMANCE STATUS; KIDNEY CARCINOMA; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; RADIATION DOSE; RETROSPECTIVE STUDY; SEX; BRAIN NEOPLASMS; CARCINOMA, RENAL CELL; CLINICAL TRIAL; EVALUATION STUDY; GERMANY; KIDNEY TUMOR; MIDDLE AGED; MORTALITY; MULTICENTER STUDY; PROCEDURES; SECONDARY; SEX DIFFERENCE; SKULL IRRADIATION; TREATMENT OUTCOME;

AGE FACTORS; AGED; BRAIN NEOPLASMS; CARCINOMA, RENAL CELL; CRANIAL IRRADIATION; FEMALE; GERMANY; HUMANS; KARNOFSKY PERFORMANCE STATUS; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; RADIOTHERAPY DOSAGE; RETROSPECTIVE STUDIES; SEX FACTORS; TREATMENT OUTCOME;

EID: 79956210614     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2009.08.022     Document Type: Article

References (30)

1. M. Wronski, M.H. Maor, and B.J. Davis External radiation of brain metastases from renal carcinoma: A retrospective study of 119 patients from the M.D. Anderson Cancer Center Int J Radiat Oncol Biol Phys 37 1997 753 759
2. S. Culine, M. Bekradda, and A. Kramar Prognostic factors for survival in patients with brain metastases from renal cell carcinoma Cancer 83 1998 2548 2553
3. M.H. Maor, A.E. Frias, and M.J. Oswald Palliative radiotherapy for brain metastases in renal carcinoma Cancer 62 1988 1912 1917
4. S.B. Cannady, K.A. Cavanaugh, and S.Y. Lee Results of whole brain radiotherapy and recursive partitioning analysis in patients with brain metastases from renal cell carcinoma: A retrospective study Int J Radiat Oncol Biol Phys 58 2004 253 258
5. P.C. Gay, W.J. Litchy, and T.L. Cascino Brain metastasis in hypernephroma J Neurooncol 5 1987 51 56
6. M. Wronski, E. Arbit, and P. Russo Surgical resection of brain metastases from renal cell carcinoma in 50 patients Urology 47 1996 187 193
7. J.P. Sheehan, M.H. Sun, and D. Kondziolka Radiosurgery in patients with renal cell carcinoma metastasis to the brain: Long-term outcomes and prognostic factors influencing survival and local tumor control J Neurosurg 98 2003 342 349
8. L.K. Goyal, J.H. Suh, and C.A. Reddy The role of whole brain radiotherapy and stereotactic radiosurgery on brain metastases from renal cell carcinoma Int J Radiat Oncol Biol Phys 47 2000 1007 1012
9. W.S. Anderson, L.E. Moore, and E. Ford Fatal case of intracerebral hemorrhage during gamma knife treatment for metastases Clin Neurol Neurosurg 110 2008 838 842
10. D. Wilson, L. Hiller, and L. Gray The effect of biological effective dose on time to symptom progression in metastatic renal cell carcinoma Clin Oncol (R Coll Radiol) 15 2003 400 407
11. S.J. DiBiase, R.K. Valicenti, and D. Schultz Palliative irradiation for focally symptomatic metastatic renal cell carcinoma: Support for dose escalation based on a biological model J Urol 158 1997 746 749
12. L. Gaspar, C. Scott, and M. Rotman Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials Int J Radiat Oncol Biol Phys 37 1997 745 751
13. E.L. Kaplan, and P. Meier Non parametric estimation from incomplete observations J Am Stat Assoc 53 1958 457 481
14. A. Trotti, R. Byhardt, and J. Stetz Common toxicity criteria: Version 2.0. An improved reference for grading the acute effects of cancer treatment: Impact on radiotherapy Int J Radiat Oncol Biol Phys 47 2000 13 47
15. H. Ikushima, K. Tokuuye, and M. Sumi Fractionated stereotactic radiotherapy of brain metastases from renal cell carcinoma Int J Radiat Oncol Biol Phys 48 2000 1389 1393
16. M.C. Joiner, and A.J. Van der Kogel The linear-quadratic approach to fractionation and calculation of isoeffect relationships G.G. Steel, Basic clinical radiobiology 1997 Oxford University Press New York 106 112
17. J.F. Fowler The radiobiology of prostate cancer including new aspects of fractionated radiotherapy Acta Oncol 44 2005 265 276
18. L.M. DeAngelis, J.Y. Delattre, and J.B. Posner Radiation-induced dementia in patients cured of brain metastases Neurology 39 1989 789 796
19. M.M. Elhilali, M. Gleave, and Y. Fradet Placebo-associated remissions in a multicentre, randomized, double-blind trial of interferon gamma-1b for the treatment of metastatic renal cell carcinoma. The Canadian Urologic Oncology Group BJU Int 86 2000 613 618
20. A.K. Koutras, D. Krikelis, and N. Alexandrou Brain metastasis in renal cell cancer responding to sunitinib Anticancer Res 27 2007 4255 4257
21. F. Thibault, B. Billemont, and O. Rixe Regression of brain metastases of renal cell carcinoma with antiangiogenic therapy J Neurooncol 86 2008 243 244
22. H.H. Helgason, H.A. Mallo, and H. Droogendijk Brain metastases in patients with renal cell cancer receiving new targeted treatment J Clin Oncol 36 2008 152 154
23. D. Pouessel, and S. Culine High frequency of intracerebral hemorrhage in metastatic renal carcinoma patients with brain metastases treated with tyrosine kinase inhibitors targeting the vascular endothelial growth factor receptor Eur Urol 53 2008 376 381
24. R.A. Patchell, P.A. Tibbs, and J.W. Walsh A randomized trial of surgery in the treatment of single metastases of the brain N Engl J Med 322 1990 494 500
25. D.W. Andrews, C.B. Scott, and P.W. Sperduto Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: Phase III results of the RTOG 9508 randomised trial Lancet 363 2004 1665 1672
26. R.A. Patchell, P.A. Tibbs, and W.F. Regine Postoperative radiotherapy in the treatment of single metastases to the brain: A randomized trial J Am Med Assoc 280 1998 1485 1489
27. H. Aoyama, H. Shirato, and M. Tago Stereotactic radiosurgery plus whole-brain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases: A randomized controlled trial J Am Med Assoc 295 2006 2483 2491
28. R.P. Muller, R. Soffietti, and M.U. Abacioglu Adjuvant whole-brain radiotherapy versus observation after radiosurgery or surgical resection of 1-3 cerebral metastases: Results of the EORTC 22952-26001 study J Clin Oncol 27 Suppl 2009
29. H. Aoyama, M. Tago, and N. Kato Neurocognitive function of patients with brain metastasis who received either whole brain radiotherapy plus stereotactic radiosurgery or radiosurgery alone Int J Radiat Oncol Biol Phys 68 2007 1388 1395
30. P. Okunieff, R.E. Meyn, and B.A. Teicher Report from the Radiation Oncology Committee of the Southwest Oncology Group (SWOG): Research Objectives Workshop 2003 Am J Clin Oncol 26 2003 522-229